Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06111131 · ClinicalTrials.gov registry record · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
A NA study of Small Bowel Disease, sponsored by Aspero Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 5
- Study locations
NCT06111131 is a NA study of Small Bowel Disease that is actively recruiting participants, run by Aspero Medical. The registered enrollment target is 123 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT06111131, a NA study of Small Bowel Disease, is actively recruiting participants, sponsored by Aspero Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 5
- Study locations
Study Summary
Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.
Conditions Studied
Interventions
- DEVICE Enteroscopy
Study Locations (5)
Maryland
- University of Maryland - Baltimore
- Johns Hopkins - Baltimore
California
- Cedars Sinai - Los Angeles
Missouri
- Washington University School of Medicine in St. Louis - St Louis
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2024-01-15 |
| Est. Completion | 2025-05-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06111131
The ClinicalTrials.gov registry entry for NCT06111131 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 123 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aspero Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Small Bowel Disease appearing as the primary indexed condition, and to 1 intervention - of which Enteroscopy is the first listed.
NCT06111131 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Maryland, California, Missouri.
Frequently Asked Questions
What is clinical trial NCT06111131 about?
NCT06111131 is a clinical study titled "Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures". Demonstrate superiority of the Aspero Medical Ancora-SB balloon Overtube compared to the Olympus ST-SB1 Balloon Overtube.
What is the current status of trial NCT06111131?
This trial is currently recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2024-01-15. Estimated completion is 2025-05-15.
What conditions does trial NCT06111131 study?
This clinical trial studies the following conditions: Small Bowel Disease.
What interventions are being tested in trial NCT06111131?
The interventions under investigation include: Enteroscopy (DEVICE).
Who is sponsoring clinical trial NCT06111131?
This trial is sponsored by Aspero Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06111131 being conducted?
This trial has 5 study locations across California, Maryland, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.